FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells.
J Immunother Cancer
; 8(2)2020 09.
Article
in En
| MEDLINE
| ID: mdl-32900860
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
T-Lymphocytes
/
Lymphocytes, Tumor-Infiltrating
/
Receptors, OX40
/
Immunotherapy
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
/
Male
Language:
En
Journal:
J Immunother Cancer
Year:
2020
Type:
Article
Affiliation country:
Netherlands